TF and COVID-19: In connection with the coagulation abnormalities observed in COVID-19 patients[69], Rosell et al. reported the presence of plasmatic EVs expressing tissue factor (TF), the main activator of the coagulation cascade; furthermore, the activity of TF-bearing EVs was linked to disease severity and mortality, and showed a correlation with D-Dimer levels[70].